Skip to main content
icon for Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?
Finance·ISRG

Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?

icon for Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?
Finance·ISRG

Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?

Jul 16

Jul 16

<12.5% 50%

12.5%-15% 50%

15%-17.5% 50%

17.5%-20% 50%

Polymarket
BARU

<12.5% 50%

12.5%-15% 50%

15%-17.5% 50%

17.5%-20% 50%

Polymarket
BARU

<12.5%

$233 Vol.

50%

12.5%-15%

$0 Vol.

50%

15%-17.5%

$0 Vol.

50%

17.5%-20%

$0 Vol.

50%

20%+

$0 Vol.

49%

This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.Intuitive Surgical’s Q2 2026 da Vinci procedure growth market reflects balanced trader views around the company’s full-year 13.5-15.5% guidance, supported by the ongoing da Vinci 5 rollout that delivers roughly 11% higher utilization than the legacy Xi system. Q1 2026 results showed 16% da Vinci procedure growth and 23% revenue expansion to $2.77 billion, driven by system placements and recurring instruments revenue, prompting management to lift the annual outlook. Key swing factors include sustained utilization trends above 4% as the installed base shifts toward da Vinci 5, international adoption rates, and competitive positioning against emerging robotic platforms. With earnings set for July 16, near-term data on procedure volumes and margins will clarify whether growth remains in the mid-teens range or accelerates further amid strong demand for advanced surgical systems.

This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.

If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.

If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.

If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.

If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.

The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.

Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Volume
$233
Tanggal Berakhir
Jul 16, 2026
Pasar Dibuka
Jul 8, 2026, 7:06 PM ET

Resolver

0x69c47De9D...
This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.Intuitive Surgical’s Q2 2026 da Vinci procedure growth market reflects balanced trader views around the company’s full-year 13.5-15.5% guidance, supported by the ongoing da Vinci 5 rollout that delivers roughly 11% higher utilization than the legacy Xi system. Q1 2026 results showed 16% da Vinci procedure growth and 23% revenue expansion to $2.77 billion, driven by system placements and recurring instruments revenue, prompting management to lift the annual outlook. Key swing factors include sustained utilization trends above 4% as the installed base shifts toward da Vinci 5, international adoption rates, and competitive positioning against emerging robotic platforms. With earnings set for July 16, near-term data on procedure volumes and margins will clarify whether growth remains in the mid-teens range or accelerates further amid strong demand for advanced surgical systems.

This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.

If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.

If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.

If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.

If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.

The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.

Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Volume
$233
Tanggal Berakhir
Jul 16, 2026
Pasar Dibuka
Jul 8, 2026, 7:06 PM ET

Resolver

0x69c47De9D...
This market will resolve according to Intuitive Surgical's da Vinci procedure growth for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?" adalah pasar prediksi di Polymarket dengan 5 hasil yang mungkin di mana trader membeli dan menjual saham berdasarkan apa yang mereka yakini akan terjadi. Hasil terdepan saat ini adalah "<12.5%" di 50%, diikuti oleh "12.5%-15%" di 50%. Harga mencerminkan probabilitas crowd-sourced real-time. Misalnya, saham yang dihargai 50¢ menyiratkan bahwa pasar secara kolektif memberikan peluang 50% pada hasil tersebut. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

"Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?" adalah pasar yang baru dibuat di Polymarket, diluncurkan pada Jul 8, 2026. Sebagai pasar awal, ini adalah kesempatanmu untuk menjadi salah satu trader pertama yang menetapkan peluang dan membangun sinyal harga awal pasar. Kamu juga bisa menandai halaman ini untuk melacak volume dan aktivitas trading seiring pasar mendapatkan traksi.

Untuk trading di "Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?," jelajahi 5 hasil yang tersedia di halaman ini. Setiap hasil menampilkan harga saat ini yang mewakili probabilitas tersirat pasar. Untuk mengambil posisi, pilih hasil yang menurutmu paling mungkin, pilih "Ya" untuk mendukungnya atau "Tidak" untuk menentangnya, masukkan jumlahmu, dan klik "Trade." Jika hasil pilihanmu benar saat pasar diselesaikan, saham "Ya" kamu membayar $1 masing-masing. Jika salah, mereka membayar $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Unggulan saat ini untuk "Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?" adalah "<12.5%" di 50%, yang berarti pasar memberikan peluang 50% pada hasil tersebut. Hasil terdekat berikutnya adalah "12.5%-15%" di 50%. Peluang ini diperbarui secara real-time saat trader membeli dan menjual saham, sehingga mencerminkan pandangan kolektif terbaru tentang apa yang paling mungkin terjadi. Cek kembali secara rutin atau tandai halaman ini untuk mengikuti bagaimana peluang bergeser saat informasi baru muncul.

Aturan resolusi untuk "Intuitive Surgical (ISRG) Q2 da Vinci procedure growth?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.